The global Cancer Tumor Profiling Market was valued at approximately USD 12.47 billion in 2025 and is projected to reach USD 26.29 billion by 2033, growing at a CAGR of around 8.2%, driven by advancements in precision medicine, genomic/proteomic profiling, and rising cancer prevalence. North America dominates (≈43% share), while Asia‑Pacific is the fastest-growing region; key innovati... https://www.datamintelligence.com/research-report/cancer-tumor-profiling-market